A polymorphism in the hMLH1 gene (-93G→A) associated with lung cancer susceptibility and prognosis

被引:17
作者
Shih, Chuen-Ming [3 ]
Chen, Chih-Yi [2 ]
Lee, I-Hsuan [1 ]
Kao, Wei-Ting [1 ]
Wang, Yi-Ching [1 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
[2] China Med Univ Hosp, Ctr Canc, Taichung, Taiwan
[3] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan
关键词
hMLH1; polymorphism; lung cancer; susceptibility; prognosis; DNA-REPAIR GENES; SINGLE-NUCLEOTIDE POLYMORPHISM; MISMATCH REPAIR; RISK; METHYLATION; PROMOTER; POPULATION; SYSTEM;
D O I
10.3892/ijmm_00000327
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Polymorph is in DNA repair genes may be associated with differences in repair capacity of DNA damage and may thereby influence an individual's susceptibility to lung cancer. We investigated the association between the -93G -> A polymorphism in the mismatch repair Wall gene for its role in the susceptibility and survival of non-small cell lung cancer (NSCLC) patients. Using a case-control study design, 165 NSCLC patients and 193 controls with similar range for age, gender and smoking habit distributions were subjected to genotype analysis. The risk of lung cancer was estimated by logistic regression analysis. The Kaplan-Meier method was used to estimate the probability of survival and the log-rank test was used to assess the significance of the difference between survival probabilities. The homozygous variant A/A genotype was associated with a significantly increased risk for lung cancer compared with the other genotypes (Crude analysis P=0.003, Adjusted analysis P=0.011, using the logistic regression model). The patients with a homozygous variant A/A genotype had a trend toward poorer prognoses compared with other patients, especially smoking (P=0.05, by log-rank test), male (P=0.06), or squamous carcinoma (P=0.08) patients. This is the first case-control study to show a significant association between the hMLH1-93G.A polymorphism and the susceptibility to and prognosis of lung cancer. The results herein may be useful for risk assessment and disease monitoring of NSCLC.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 20 条
  • [1] Epidemiology of lung cancer: Looking to the future
    Alberg, AJ
    Brock, MV
    Samet, JM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3175 - 3185
  • [2] Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population
    An, Yu
    Jin, Guangfu
    Wang, Haifeng
    Wang, Yi
    Liu, Hongliang
    Li, Rui
    Wang, Haijian
    Qian, Ji
    Sun, Weiwei
    Wang, Yi
    Ma, Hongxia
    Miao, Ruifeng
    Hu, Zhibin
    Jin, Li
    Wei, Qingyi
    Shen, Hongbing
    Huang, Wei
    Lu, Daru
    [J]. LUNG CANCER, 2008, 59 (02) : 164 - 170
  • [3] Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives
    Cassidy, A.
    Myles, J. P.
    Duffy, S. W.
    Liloglou, T.
    Field, J. K.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (09) : 1288 - 1290
  • [4] Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas
    Deng, DJ
    Zhou, J
    Zhu, BD
    Ji, JF
    Harper, JC
    Powell, SM
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (01) : 26 - 29
  • [5] *DEP HLTH EX YUAN, 2006, PUBL HLTH TAIW AR, P47
  • [6] Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSM2 deregulation and is a poor prognostic factor in nonsmoking lung cancer
    Hsu, HS
    Wen, CK
    Tang, YA
    Lin, RK
    Li, WY
    Hsu, WH
    Wang, YC
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5410 - 5416
  • [7] A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1
    Ito, E
    Yanagisawa, Y
    Iwahashi, Y
    Suzuki, Y
    Nagasaki, H
    Akiyama, Y
    Sugano, S
    Yuasa, Y
    Maruyama, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (03) : 488 - 494
  • [8] Kim Jin C, 2004, Fam Cancer, V3, P129
  • [9] MISMATCH REPAIR - MECHANISMS AND RELATIONSHIP TO CANCER SUSCEPTIBILITY
    KOLODNER, RD
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (10) : 397 - 401
  • [10] KOLODNER RD, 1995, CANCER RES, V55, P242